Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13895963 | 0.94 | TYR (0.46) | TYRALOX5PTGS2EGFRHTT | |
| SCHEMBL172598 | 0.90 | CA1 (0.54) | TYRALOX5PTGS2EGFRHTT | |
| SCHEMBL12457001 | 0.88 | TYR (0.46) | TYRALOX5PTGS2EGFRHTT | |
| SCHEMBL1760464 | 0.86 | ALOX5 (0.61) | TYRALOX5PTGS2EGFRHTT | |
| SCHEMBL10407157 | 0.86 | PTGS2 (0.51) | TYRALOX5PTGS2HTTCYP3A4 | |
| SCHEMBL8975468 | 0.85 | ALOX5 (0.44) | ALOX5PTGS2 | |
| SCHEMBL14037093 | 0.85 | CA1 (0.43) | TYRALOX5PTGS2EGFRHTT | |
| SCHEMBL1023197 | 0.85 | TYR (0.43) | TYRALOX5PTGS2EGFRHTT | |
| SCHEMBL280118 | 0.84 | TYR (0.48) | TYRALOX5PTGS2EGFRHTT | |
| SCHEMBL201692 | 0.84 | NPC1 (0.57) | TYRALOX5PTGS2EGFRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8007426-B2 | Developing roller | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-20110177338-A1 | CARBON BLACK | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-7951310-B2 | Nanophase carbon black grafted with organic compound in situ | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2011-05-31 | — | — | US | disclosed |
| US-20100119437-A1 | METHOD FOR PRODUCING CARBON BLACK | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2010-05-13 | — | — | US | disclosed |
| US-20100004333-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISORDERS | STOCKER ROLAND O | 2010-01-07 | — | — | US | disclosed |
| US-20090226722-A1 | CARBON BLACK | UHIDA MASAFUMI | 2009-09-10 | — | — | US | disclosed |
| US-20090214865-A1 | CARBON BLACK | KONICA MINOLTA BUSHINESS TECHNOLOGIES INC. (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090087766-A1 | TONER FOR DEVELOPING ELECTROSTATIC LATENT IMAGE | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090035027-A1 | DEVELOPING ROLLER | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-7466326-B2 | Image forming method and image forming apparatus | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2008-12-16 | — | — | US | disclosed |
| EP-1521806-A1 | THERMOPLASTIC POLYCARBONATE COMPOSITIONS HAVING HIGH TOUGHNESS | Bayer MaterialScience LLC (US) | 2005-04-13 | — | — | EP | disclosed |
| US-20040186233-A1 | Molding composition containing (CO)polycarbonates | BAYER MATERIALSCIENCE AG (DE) | 2004-09-23 | — | — | US | disclosed |
| US-6753405-B2 | MORE THAN 35 MOLE % OF UNITS DERIVED FROM DIHYDROXYDIPHENYLENE AND THE REST FROM AN ALKYLIDENE OR CYCLOALKYLIDENE BISPHENOL; PREPARED BY MELT TRANSESTERIFICATION; USED TO PREPARE TRANSPARENT MOLDINGS | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-22 | — | — | US | disclosed |
| US-6740714-B2 | RESISTANCE TO STRESS CRACKING AND GOOD LOW- TEMPERATURE PROPERTIES IS SUITABLE FOR AUTOMOTIVE CONSTRUCTION AND EXTERIOR APPLICATIONS; MOLDING MATERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 2004-05-25 | — | — | US | disclosed |
| US-6730748-B2 | HIGH IMPACT STRENGTH; COLD RESISTANCE; 4,4*-DIHYDROXYBIPHENYL DERIVATIVE MONOMERS | BAYER POLYMERS LLC | 2004-05-04 | — | — | US | disclosed |
| WO-2004005401-A1 | THERMOPLASTIC POLYCARBONATE COMPOSITIONS HAVING HIGH TOUGHNESS | BAYER MATERIALSCIENCE LLC (US) | 2004-01-15 | — | — | WO | disclosed |
| US-20040010097-A1 | Thermoplastic polycarbonate compositions having high toughness | BAYER CORPORATION | 2004-01-15 | — | — | US | disclosed |
| US-20030040586-A1 | Polycarbonate blends | COVESTRO DEUTSCHLAND AG (DE) | 2003-02-27 | — | — | US | disclosed |
| US-20030027971-A1 | Preparation of copolycarbonates | BAYER AKTIENGESELLSCHAFT (DE) | 2003-02-06 | — | — | US | disclosed |
| US-5098965-A | Etherification of biphenol with epichlorohydrin by dehydrochlorination | SHELL OIL COMPANY (US) | 1992-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004333-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISORDERS | SCLY, SELENOI, CBS | TYR 147/4885ALOX5 235/4885PTGS2 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.